0
Adicet Bio, Inc. Banner Image

Adicet Bio, Inc.

  • Ticker ACET
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Adicet Bio, Inc. Logo Image
  • 51-200 Employees
  • Based in Redwood City, California
Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs) and chimeric antigen adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune responseMore for durable activity in patients.
REPORT RATINGS
5.0 / 5.0 (2)

Adicet Bio, Inc. reports have an aggregate usefulness score of 5.0 based on 2 reviews.

Adicet Bio, Inc.

Most Recent Annual Report

Adicet Bio, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Adicet Bio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!